Total trials
79
Active
13
Phase 3
5
Total enrollment
6,889
Pipeline matrix
Showing 2 of 2 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Glucagon for | — | — | — | — | — | 1 | |
| Blood sample for DNA analysis | — | — | — | — | — | 1 |
Next readouts
- 2026-06-01
- 2026-12
Top conditions
- Obesity13
- Hypoglycemia12
- Type 1 Diabetes12
- Diabetes10
- Type 2 Diabetes Mellitus8
- Type 2 Diabetes8
- Type 1 Diabetes Mellitus5
- Insulin Resistance4
Frequently asked questions about Joslin Diabetes Center
- How many clinical trials does Joslin Diabetes Center have on ClinicalTrials.gov?
- Joslin Diabetes Center is listed as the lead sponsor on 79 clinical trials in ClinicalTrials.gov, 13 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Joslin Diabetes Center's trials are in Phase 3?
- 5 of Joslin Diabetes Center's trials are in Phase 3, spread across 2 active drug programs.
- What therapeutic areas does Joslin Diabetes Center focus on?
- Joslin Diabetes Center's most-studied conditions on ClinicalTrials.gov are Obesity, Hypoglycemia, Type 1 Diabetes, Diabetes, Type 2 Diabetes Mellitus.
- When are Joslin Diabetes Center's next clinical trial readouts?
- Joslin Diabetes Center has 2 upcoming primary-completion readouts tracked here; the soonest is “Glucagon Dose-Response in Patients With Post-Bariatric Hypoglycemia”, expected around 2026-06-01.